AI-based drug developer Recursion’s stock barely moved Wednesday, then dropped Thursday and Friday, after reporting mixed third quarter results, setting the stage for future pipeline announcements—and ...

In this Sunday edition of Business Insider Today, we're talking about the highs and lows of AI in the workforce so far.

A significant number of men use supplements sourced locally or through the internet whose quality is not assured and may not ...